Our findings corroborate previous observations in other populations, indicating that the distribution of APOE alleles (including specifically ε4 carrier rates), ε4 or ε2 allele dosage, and APOE genotypes are not significantly different between PD and controls18,19. This evidence concerns the gene APOE and Parkinson disease.